KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

AbbVie (ABBV) Consolidated Net Income (2016 - 2025)

AbbVie (ABBV) has disclosed Consolidated Net Income for 14 consecutive years, with $1.8 billion as the latest value for Q4 2025.

  • Quarterly Consolidated Net Income rose 7991.3% to $1.8 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.2 billion through Dec 2025, down 1.24% year-over-year, with the annual reading at $4.2 billion for FY2025, 1.24% down from the prior year.
  • Consolidated Net Income for Q4 2025 was $1.8 billion at AbbVie, up from $188.0 million in the prior quarter.
  • The five-year high for Consolidated Net Income was $4.5 billion in Q1 2022, with the low at -$97.0 million in Q1 2023.
  • Average Consolidated Net Income over 5 years is $1.8 billion, with a median of $1.5 billion recorded in 2024.
  • The sharpest move saw Consolidated Net Income surged 10544.74% in 2021, then plummeted 102.79% in 2024.
  • Over 5 years, Consolidated Net Income stood at $4.0 billion in 2021, then crashed by 38.89% to $2.5 billion in 2022, then tumbled by 66.67% to $824.0 million in 2023, then tumbled by 102.79% to -$23.0 million in 2024, then skyrocketed by 7991.3% to $1.8 billion in 2025.
  • According to Business Quant data, Consolidated Net Income over the past three periods came in at $1.8 billion, $188.0 million, and $941.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.